Remove 2024 Remove Compounding Remove Dosage
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

article thumbnail

Common Findings from NABP Pharmacy Inspections

National Association of Boards of Pharmacy

This blog post will identify key areas where gaps were identified against USP compounding chapter standards during VPP inspections in the 12 months after the revised compounding chapters went into effect. Beyond Use Dates for aqueous dosage units exceeded Table 4. Floors were not cleaned daily, when compounding occurred.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Therapeutic Guidelines, Australian Medicines Handbook and APF

RX Note

Given that public healthcare is centrally provided by government hospitals and clinics, prescribing practices are guided by the Ministry of Health Medicines Formulary and local formularies.

article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

Suggestions for providers featured in the guidelines include determining if opioids should take place, selecting appropriate dosages, determining prescription length and follow-up, and assessing and reducing risks of misuse, overdose, and opioid use disorder. Published May 6, 2024. MMWR Recommendations and Reports. 2022;71(3):1-95.

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.

article thumbnail

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacy Times

This phase 1b clinical trial, conducted between September 2023 and November 2024, was designed to build on promising preclinical data that demonstrated improved efficacy and tolerability with continuous SC lenalidomide delivery in murine MM models. It will be interesting to see what dosage form these data prompt the future development of.

article thumbnail

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

FluMist (live intranasal influenza vaccine; AstraZeneca) was approved in September 2024 for self- and caregiver administration for individuals aged 2 to 49 years. 8 This percentage is lower than the previous season (53%), which contributed to 250 pediatric deaths during the 2024-2025 influenza season. September 17, 2024.